# Vistra Corp.: financial statements, quarterly

VST · NYSE · CIK 1692819 · [Utilities](/sectors/utilities.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/vst.md) · [Financials](/companies/vst/financials.md) · [Filings](/companies/vst/filings.md) · [Insiders](/companies/vst/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/vst/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [4,789](/filings/0001692819-24-000069.md) | [2,880 d](/filings/0001692819-26-000006.md) | [3,159](/filings/0001692819-25-000035.md) | [3,599](/filings/0001692819-25-000085.md) | [4,341](/filings/0001692819-25-000094.md) | [3,662 d](/filings/0001692819-26-000006.md) | [4,250](/filings/0001692819-26-000014.md) | [3,753](/filings/0001692819-26-000019.md) | [4,778](/filings/0001692819-25-000094.md) | [4,805 d](/filings/0001692819-26-000006.md) | [5,001](/filings/0001692819-26-000014.md) | [4,401](/filings/0001692819-26-000019.md) |
| Selling, general and administrative | $m | [357](/filings/0001692819-24-000069.md) | [355 d](/filings/0001692819-26-000006.md) | [351](/filings/0001692819-25-000035.md) | [375](/filings/0001692819-25-000085.md) | [411](/filings/0001692819-25-000094.md) | [464 d](/filings/0001692819-26-000006.md) | [391](/filings/0001692819-26-000014.md) | [419](/filings/0001692819-26-000019.md) | [444](/filings/0001692819-25-000094.md) | [460 d](/filings/0001692819-26-000006.md) | [427](/filings/0001692819-26-000014.md) | [392](/filings/0001692819-26-000019.md) |
| Operating income | $m | [834](/filings/0001692819-24-000069.md) | [102 d](/filings/0001692819-26-000006.md) | [86.0](/filings/0001692819-25-000035.md) | [808](/filings/0001692819-25-000085.md) | [2,588](/filings/0001692819-25-000094.md) | [599 d](/filings/0001692819-26-000006.md) | [(120)](/filings/0001692819-26-000014.md) | [515](/filings/0001692819-26-000019.md) | [1,037](/filings/0001692819-25-000094.md) | [474 d](/filings/0001692819-26-000006.md) | [1,499](/filings/0001692819-26-000014.md) | [553](/filings/0001692819-26-000019.md) |
| Interest expense | $m | [143](/filings/0001692819-24-000069.md) | [290 d](/filings/0001692819-24-000012.md) | [170](/filings/0001692819-24-000033.md) | [241](/filings/0001692819-24-000061.md) | [332](/filings/0001692819-24-000069.md) | [157 d](/filings/0001692819-26-000006.md) | [319](/filings/0001692819-26-000014.md) | [303](/filings/0001692819-26-000019.md) | [286](/filings/0001692819-25-000094.md) | [271 d](/filings/0001692819-26-000006.md) | [263](/filings/0001692819-26-000014.md) | [312](/filings/0001692819-26-000019.md) |
| Income tax | $m | [169](/filings/0001692819-24-000069.md) | [38.0 d](/filings/0001692819-26-000006.md) | [(20.0)](/filings/0001692819-25-000035.md) | [159](/filings/0001692819-25-000085.md) | [555](/filings/0001692819-25-000094.md) | [(39.0) d](/filings/0001692819-26-000006.md) | [(176)](/filings/0001692819-26-000014.md) | [76.0](/filings/0001692819-26-000019.md) | [204](/filings/0001692819-25-000094.md) | [75.0 d](/filings/0001692819-26-000006.md) | [183](/filings/0001692819-26-000014.md) | [122](/filings/0001692819-26-000019.md) |
| Net income | $m | [502](/filings/0001692819-24-000069.md) | [(184) d](/filings/0001692819-26-000006.md) | [(35.0)](/filings/0001692819-25-000035.md) | [365](/filings/0001692819-25-000085.md) | [1,888](/filings/0001692819-25-000094.md) | [441 d](/filings/0001692819-26-000006.md) | [(268)](/filings/0001692819-26-000014.md) | [327](/filings/0001692819-26-000019.md) | [652](/filings/0001692819-25-000094.md) | [233 d](/filings/0001692819-26-000006.md) | [1,029](/filings/0001692819-26-000014.md) | [305](/filings/0001692819-26-000019.md) |
| Diluted EPS | $ per share | [1.25](/filings/0001692819-24-000069.md) | not reported | [(0.24)](/filings/0001692819-25-000035.md) | [0.90](/filings/0001692819-25-000085.md) | [5.25](/filings/0001692819-25-000094.md) | not reported | [(0.93)](/filings/0001692819-26-000014.md) | [0.81](/filings/0001692819-26-000019.md) | [1.75](/filings/0001692819-25-000094.md) | not reported | [2.87](/filings/0001692819-26-000014.md) | [0.76](/filings/0001692819-26-000019.md) |
| Basic EPS | $ per share | [1.27](/filings/0001692819-24-000069.md) | not reported | [(0.24)](/filings/0001692819-25-000035.md) | [0.92](/filings/0001692819-25-000085.md) | [5.36](/filings/0001692819-25-000094.md) | not reported | [(0.93)](/filings/0001692819-26-000014.md) | [0.82](/filings/0001692819-26-000019.md) | [1.78](/filings/0001692819-25-000094.md) | not reported | [2.90](/filings/0001692819-26-000014.md) | [0.77](/filings/0001692819-26-000019.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [3.2](/filings/0001628280-23-037205.md) | [3.5](/filings/0001692819-25-000013.md) | [1.1](/filings/0001692819-24-000033.md) | [1.6](/filings/0001692819-24-000061.md) | [0.9](/filings/0001692819-24-000069.md) | [1.2](/filings/0001692819-26-000006.md) | [0.6](/filings/0001692819-25-000035.md) | [0.5](/filings/0001692819-25-000085.md) | [0.6](/filings/0001692819-25-000094.md) | [0.8](/filings/0001692819-26-000019.md) | [0.6](/filings/0001692819-26-000014.md) | [0.4](/filings/0001692819-26-000019.md) |
| Current assets | $bn | [10.7](/filings/0001628280-23-037205.md) | [11.6](/filings/0001692819-25-000013.md) | [9.4](/filings/0001692819-24-000033.md) | [9.8](/filings/0001692819-24-000061.md) | [8.5](/filings/0001692819-24-000069.md) | [8.1](/filings/0001692819-26-000006.md) | [8.4](/filings/0001692819-25-000035.md) | [8.5](/filings/0001692819-25-000085.md) | [8.4](/filings/0001692819-25-000094.md) | [9.2](/filings/0001692819-26-000019.md) | [9.0](/filings/0001692819-26-000014.md) | [10.3](/filings/0001692819-26-000019.md) |
| Total assets | $bn | [31.9](/filings/0001628280-23-037205.md) | [33.0](/filings/0001692819-25-000013.md) | [38.2](/filings/0001692819-24-000033.md) | [39.1](/filings/0001692819-24-000061.md) | [37.9](/filings/0001692819-24-000069.md) | [37.8](/filings/0001692819-26-000006.md) | [38.2](/filings/0001692819-25-000035.md) | [38.1](/filings/0001692819-25-000085.md) | [38.0](/filings/0001692819-25-000094.md) | [41.6](/filings/0001692819-26-000019.md) | [41.3](/filings/0001692819-26-000014.md) | [42.6](/filings/0001692819-26-000019.md) |
| Current liabilities | $bn | [8.7](/filings/0001628280-23-037205.md) | [9.8](/filings/0001692819-25-000013.md) | [8.8](/filings/0001692819-24-000033.md) | [10.1](/filings/0001692819-24-000061.md) | [7.7](/filings/0001692819-24-000069.md) | [8.4](/filings/0001692819-26-000006.md) | [9.8](/filings/0001692819-25-000035.md) | [9.4](/filings/0001692819-25-000085.md) | [8.4](/filings/0001692819-25-000094.md) | [11.8](/filings/0001692819-26-000019.md) | [10.1](/filings/0001692819-26-000014.md) | [10.6](/filings/0001692819-26-000019.md) |
| Total liabilities | $bn | [26.4](/filings/0001628280-23-037205.md) | [27.6](/filings/0001692819-25-000013.md) | [30.9](/filings/0001692819-24-000033.md) | [31.8](/filings/0001692819-24-000061.md) | [29.2](/filings/0001692819-24-000069.md) | [32.2](/filings/0001692819-26-000006.md) | [33.4](/filings/0001692819-25-000035.md) | [33.3](/filings/0001692819-25-000085.md) | [32.8](/filings/0001692819-25-000094.md) | [36.4](/filings/0001692819-26-000019.md) | [35.7](/filings/0001692819-26-000014.md) | [37.1](/filings/0001692819-26-000019.md) |
| Long-term debt | $bn | not reported | [14.4](/filings/0001692819-25-000013.md) | not reported | [15.9](/filings/0001692819-24-000061.md) | [14.7](/filings/0001692819-24-000069.md) | [16.3](/filings/0001692819-26-000006.md) | [16.3](/filings/0001692819-25-000035.md) | [15.8](/filings/0001692819-25-000085.md) | [16.0](/filings/0001692819-25-000094.md) | [17.0](/filings/0001692819-26-000019.md) | [19.2](/filings/0001692819-26-000014.md) | [19.6](/filings/0001692819-26-000019.md) |
| Short-term borrowings | $bn | [0.0](/filings/0001628280-23-037205.md) | [0.0](/filings/0001692819-24-000061.md) | [0.5](/filings/0001692819-24-000033.md) | [0.0](/filings/0001692819-24-000061.md) | not reported | [0.0](/filings/0001692819-26-000006.md) | [1.4](/filings/0001692819-25-000035.md) | [0.9](/filings/0001692819-25-000085.md) | not reported | [1.8](/filings/0001692819-26-000019.md) | [0.0](/filings/0001692819-26-000014.md) | [0.0](/filings/0001692819-26-000019.md) |
| Shareholders' equity | $bn | [5.5](/filings/0001628280-23-037205.md) | [5.3](/filings/0001692819-25-000013.md) | [5.7](/filings/0001692819-24-000033.md) | [5.6](/filings/0001692819-24-000061.md) | [5.4](/filings/0001692819-24-000069.md) | [5.6](/filings/0001692819-26-000006.md) | [4.8](/filings/0001692819-25-000035.md) | [4.8](/filings/0001692819-25-000085.md) | [5.2](/filings/0001692819-25-000094.md) | [5.1](/filings/0001692819-26-000019.md) | [5.6](/filings/0001692819-26-000014.md) | [5.5](/filings/0001692819-26-000019.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [1,560 d](/filings/0001692819-24-000069.md) | [881 d](/filings/0001692819-26-000006.md) | [312](/filings/0001692819-25-000035.md) | [1,196 d](/filings/0001692819-25-000085.md) | [1,702 d](/filings/0001692819-25-000094.md) | [1,353 d](/filings/0001692819-26-000006.md) | [599](/filings/0001692819-26-000014.md) | [572 d](/filings/0001692819-26-000019.md) | [1,467 d](/filings/0001692819-25-000094.md) | [1,432 d](/filings/0001692819-26-000006.md) | [1,199](/filings/0001692819-26-000014.md) | [1,023 d](/filings/0001692819-26-000019.md) |
| Capital expenditure | $m | [336 d](/filings/0001692819-24-000069.md) | [414 d](/filings/0001692819-26-000006.md) | [465](/filings/0001692819-25-000035.md) | [498 d](/filings/0001692819-25-000085.md) | [685 d](/filings/0001692819-25-000094.md) | [430 d](/filings/0001692819-26-000006.md) | [768](/filings/0001692819-26-000014.md) | [690 d](/filings/0001692819-26-000019.md) | [458 d](/filings/0001692819-25-000094.md) | [836 d](/filings/0001692819-26-000006.md) | [883](/filings/0001692819-26-000014.md) | [689 d](/filings/0001692819-26-000019.md) |
| Dividends paid | $m | [75.0 d](/filings/0001692819-24-000069.md) | [85.0 d](/filings/0001692819-26-000006.md) | [77.0](/filings/0001692819-25-000035.md) | [73.0 d](/filings/0001692819-25-000085.md) | [80.0 d](/filings/0001692819-25-000094.md) | [75.0 d](/filings/0001692819-26-000006.md) | [83.0](/filings/0001692819-26-000014.md) | [69.0 d](/filings/0001692819-26-000019.md) | [77.0 d](/filings/0001692819-25-000094.md) | [77.0 d](/filings/0001692819-26-000006.md) | [77.0](/filings/0001692819-26-000014.md) | [77.0 d](/filings/0001692819-26-000019.md) |
| Share repurchases | $m | [314 d](/filings/0001692819-24-000069.md) | [379 d](/filings/0001692819-26-000006.md) | [291](/filings/0001692819-25-000035.md) | [331 d](/filings/0001692819-25-000085.md) | [399 d](/filings/0001692819-25-000094.md) | [245 d](/filings/0001692819-26-000006.md) | [337](/filings/0001692819-26-000014.md) | [252 d](/filings/0001692819-26-000019.md) | [187 d](/filings/0001692819-25-000094.md) | [252 d](/filings/0001692819-26-000006.md) | [372](/filings/0001692819-26-000014.md) | [337 d](/filings/0001692819-26-000019.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [417](/filings/0001628280-23-037205.md) | [388](/filings/0001692819-24-000033.md) | [377](/filings/0001692819-24-000061.md) | [372](/filings/0001692819-24-000069.md) | [349](/filings/0001692819-25-000035.md) | [354](/filings/0001692819-25-000085.md) | [350](/filings/0001692819-25-000094.md) | [340](/filings/0001692819-26-000014.md) | [346](/filings/0001692819-26-000019.md) | [345](/filings/0001692819-25-000094.md) | [342](/filings/0001692819-26-000014.md) | [339](/filings/0001692819-26-000019.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 335,635,195 at 2026-08-03, from the cover of the [10-Q filed 2026-08-10](/filings/0001692819-26-000019.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:46 ET. No prices; not investment advice.